Significance of serum and pathological biomarkers in fertility-sparing treatment for endometrial cancer or atypical hyperplasia: a retrospective cohort study

被引：0
作者：
Yiqin Wang
Rong Zhou
Xiaobo Zhang
Huixin Liu
Danhua Shen
Jianliu Wang
机构：
[1] Peking University People’s Hospital,Department of Obstetrics and Gynecology
[2] Peking University People’s Hospital,Department of Pathology
[3] Peking University People’s Hospital,Department of Clinical Epidemiology
来源：
BMC Women's Health | / 21卷
关键词：
Endometrial cancer; Endometrial atypical hyperplasia; Fertility-sparing; Insulin resistance; Progesterone receptor; Treatment efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 152 条
  • [1] Qin Y(2016)Oral progestin treatment for early-stage endometrial cancer: a systematic review and meta-analysis Int J Gynecol Cancer 26 1081-1091
  • [2] Yu Z(2016)Endometrial cancer Lancet 387 1094-1108
  • [3] Yang J(2014)Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies Gynecol Oncol 135 163-171
  • [4] Cao D(2020)Diabetes mellitus is associated with occult cancer in endometrial hyperplasia Pathol Oncol Res 26 1377-1384
  • [5] Yu M(2019)Relationship between hypothyroidism and endometrial cancer Aging Dis 10 190-196
  • [6] Wang Y(2019)Endocrine therapy in endometrial cancer: an old dog with new tricks Gynecol Oncol 153 175-183
  • [7] Shen K(2019)Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients J Gynecol Oncol 30 e90-1685
  • [8] Morice P(2010)Diabetes and cancer: a consensus report Diabetes Care 33 1674-937
  • [9] Leary A(2013)Diabetes mellitus and cancer risk: review of the epidemiological evidence Cancer Sci 104 1-525
  • [10] Creutzberg C(2019)Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment Gynecol Endocrinol 35 932-1521
12345678910